Univariate analysis of mucin expression
| Antibody | Recurrence group (%) | Non-recurrence group (%) | Univariate analysis | ||
|---|---|---|---|---|---|
| OR | 95% CI | p Value | |||
| *In Fisher’s exact test, the rate of high expression of MUC1/DF3 in the primary lesions of the recurrence group was significantly higher than that of the non-recurrence group (p = 0.016). | |||||
| CI, confidence interval; HEG, the high expression group composed of the ++ cases (more than 30% of the neoplastic cells stained); LEG, the low expression group composed of the − and + cases (less than 30% of neoplastic cells stained); ND, not determined; OR, odds ratio. | |||||
| MUC1/CORE | |||||
| LEG | 8 (89) | 35 (88) | 1 | ||
| HEG | 1 (11) | 5 (12) | 1.14 | 0.12 to 11.18 | 0.91 |
| MUC1/DF3 | |||||
| LEG | 5 (56) | 37 (92) | 1 | ||
| HEG | 4 (44)* | 3 (8) | 9.87 | 1.69 to 57.61 | 0.011 |
| MUC1/MY.1E12 | |||||
| LEG | 7 (78) | 34 (85) | 1 | ||
| HEG | 2 (22) | 6 (15) | 0.62 | 0.10 to 3.72 | 0.60 |
| MUC1/glycoprotein | |||||
| LEG | 7 (78) | 34 (85) | 1 | ||
| HEG | 2 (22) | 6 (15) | 0.62 | 0.10 to 3.72 | 0.60 |
| MUC1/HMFG-1 | |||||
| LEG | 8 (89) | 40 (100) | |||
| HEG | 1 (11) | 0 (0) | – | – | ND |
| MUC2 | |||||
| LEG | 9 (100) | 40 (100) | |||
| HEG | 0 (0) | 0 (0) | – | – | ND |
| MUC4 | |||||
| LEG | 9 (100) | 40 (100) | |||
| HEG | 0 (0) | 0 (0) | – | – | ND |
| MUC5AC | |||||
| LEG | 9 (100) | 40 (100) | |||
| HEG | 0 (0) | 0 (0) | – | – | ND |
| MUC6 | |||||
| LEG | 8 (89) | 36 (90) | 1 | ||
| HEG | 1 (11) | 4 (10) | 0.89 | 0.09 to 9.06 | 0.92 |